Document Detail


Supply and demand: negotiating the prescription drug labyrinth to reduce costs.
MedLine Citation:
PMID:  12608116     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prescription drug costs are increasing at a rate of 15% to 17% a year and a look into the future does not bring much better news. Employers can expect to see more numbers like these as doctors more aggressively treat diseases using drug therapy, the population continues to age and pharmaceutical companies continue to spend billions of dollars on direct-to-consumer advertising aimed at consumers who are desensitized to the true costs of their prescriptions. In this environment, it is unlikely that companies can realistically expect to reverse costs of even to avoid cost increases. However, this article provides employers with a prudent approach to managing both the supply and demand sides of the prescription drug equation in order to reduce their level of increase. Supply-side management focuses on negotiations with vendors, while the demand side focuses on managing employee utilization.
Authors:
Kevin DeStefino
Related Documents :
15912696 - Biocide dosing remains difficult.
8521766 - Drug utilisation review (dur) of the third generation cephalosporins. focus on ceftriax...
7493196 - Design and assessment of cost-effectiveness studies in aids populations.
7977436 - Consensus statement: benefits versus risks of medical therapy for acromegaly.
19144966 - D-cycloserine potentiates the reconsolidation of cocaine-associated memories.
18393816 - Preparation and evaluation of buccal bioadhesive tablets containing clotrimazole.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Benefits quarterly     Volume:  19     ISSN:  8756-1263     ISO Abbreviation:  Benefits Q     Publication Date:  2003  
Date Detail:
Created Date:  2003-02-28     Completed Date:  2003-03-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9112812     Medline TA:  Benefits Q     Country:  United States    
Other Details:
Languages:  eng     Pagination:  30-7     Citation Subset:  H    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cost Control / methods
Drug Costs*
Drugs, Generic / economics
Health Benefit Plans, Employee / economics,  organization & administration*
Health Services Needs and Demand*
Humans
Insurance, Pharmaceutical Services / economics*
Negotiating*
Postal Service
United States
Chemical
Reg. No./Substance:
0/Drugs, Generic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The tough decisions that no one wants to make.
Next Document:  The role of the PBM in total health management strategies for individuals with chronic conditions.